HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Walter Weder Didier Lardinois Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Weder, W. Articles by Bloch, K. E. Search for Related Content PubMed PubMed Citation Articles by Weder, W. Articles by Bloch, K. E. Related Collections Lung - other

---

Original Articles: General Thoracic

Persistent Benefit From Lung Volume Reduction Surgery in Patients With Homogeneous Emphysema

Division of Thoracic Surgery and Pulmonary Division, University Hospital, Zurich, Switzerland

Accepted for publication October 8, 2008.

^_* Address correspondence to Dr Weder, Division of Thoracic Surgery, Raemistr.100, University Hospital of Zurich, Zürich, CH- 8091, Switzerland (Email: walter.weder{at}usz.ch).

Presented at the Forty-fourth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 28–30, 2008.

Background: The purpose of this study was to evaluate whether favorable short-term results achieved by lung volume reduction surgery in selected patients with homogeneous emphysema would persist for longer periods. Their symptoms, lung function, and survival for several years were analyzed in comparison to patients with heterogeneous emphysema.

Methods: Two hundred fifty consecutive patients (105 women), mean (± standard deviation) age 64 ± 8.4 years, with advanced emphysema underwent bilateral thoracoscopic lung volume reduction surgery. Forced expiratory volume in 1 second was 28% ± 8% of predicted, 6-minute walking distance was 245 ± 118 m, and Medical Research Council dyspnea score was 3.5 ± 0.7. In 138 patients (55%) computed tomography revealed homogeneous emphysema (including 82 intermediate type) distribution and in 112 patients (45%) heterogeneous emphysema. Baseline characteristics were otherwise similar in the two groups that were prospectively observed for several years.

Results: Thirty-day mortality was 2.4%. Both groups revealed significant improvements 3 months after lung volume reduction surgery: in homogeneous emphysema, predicted forced expiratory volume in 1 second was 38% ± 14% (35% improvement), 6-minute walk distance was 324 ± 87 m, and dyspnea score was 1.8 ± 0.9 (p < 0.05 all outcomes). Corresponding results in heterogeneous emphysema were 44% ± 15% (61% improvement), 382 ± 95 m, and 1.3 ± 0.9 points (p < 0.05 versus baseline; not significant versus homogeneous). Median time until predicted forced expiratory volume in 1 second and 6-minute walk distance had returned to baseline was 36 months in both groups. One-year survival was similar in both groups. At 5 years, median survival without lung transplantation was 64% in the homogeneous and 73% in the heterogeneous group (Cox proportional hazard, 0.81; 95% confidence interval, 0.66 to 0.98; p = 0.03).

Conclusions: In selected patients with homogeneous pulmonary emphysema, lung volume reduction surgery can be successfully performed with low perioperative mortality. Significant improvements in dyspnea, lung function, and exercise capacity are maintained for several years.